ECG
The funds will be used to enhance the company's development of the Brain-Data-as-a-Service Ecosystem and expand its platform’s brain database.
Cardio Intelligence is now testing its latest AI for detecting paroxysmal atrial fibrillation.
Also, Royal Philips has expanded the roll-out of its AR surgical navigation solution to Japan.
Also, Max Life in India has developed an analytics solution that detects inaccurate medical reports in real time.
The clearance signals the company's move to offer medical AI devices to consumers.
The company is also close to getting its patent for the Us2.v1 software recognised in the US.
The non-prick device can measure blood glucose and monitor blood pressure without pressure cuffs.
Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.
Developed by researchers from an Australian university, the software can also detect a baby's face in a hospital bed.
The tech giant got both tools included in the Australian Register of Therapeutic Goods as Class IIa medical devices.